FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220932718> ?p ?o ?g. }

• W4220932718 abstract "There are no head-to-head clinical studies comparing chimeric antigen receptor (CAR) T-cell therapies for the treatment of relapsed or refractory aggressive large B-cell lymphomas. Naive, indirect comparisons may be inappropriate, as the study designs and patient populations could differ substantially. Matching-adjusted indirect comparisons (MAIC) can reduce many biases associated with indirect comparisons between studies. To determine the comparative efficacy and safety of lisocabtagene maraleucel (liso-cel) to tisagenlecleucel, we describe an unanchored MAIC of the pivotal studies TRANSCEND NHL 001 (TRANSCEND; NCT02631044; liso-cel) and JULIET (NCT02445248; tisagenlecleucel).Individual patient data (IPD) from TRANSCEND were available to the authors; for the JULIET pivotal study, summary-level data from the published study were used. To balance the populations between two studies, IPD from TRANSCEND were adjusted to match the marginal distribution (e.g., mean, variance) of clinical factors among patients from JULIET.Results from the primary MAIC showed liso-cel had statistically significant greater efficacy than tisagenlecleucel (objective response rate: odds ratio [OR] = 2.78, 95% confidence interval [CI]: 1.63‒4.74; complete response rate: OR = 2.01, 95% CI: 1.22‒3.30; progression-free survival: hazard ratio [HR] = 0.65, 95% CI: 0.47‒0.91; overall survival: HR = 0.67, 95% CI: 0.47‒0.95). MAIC of safety outcomes showed lower ORs for all-grade and grade ≥ 3 cytokine release syndrome, and grade ≥ 3 prolonged cytopenia for liso-cel when compared with tisagenlecleucel; there were no statistically significant differences detected for other safety outcomes.Overall, this MAIC of two CAR T-cell therapies indicates liso-cel had favorable efficacy and a comparable or better safety profile relative to tisagenlecleucel.ClinicalTrials.gov identifiers: NCT02631044 and NCT02445248." @default.
• W4220932718 created "2022-04-03" @default.
• W4220932718 creator A5008075505 @default.
• W4220932718 creator A5016684714 @default.
• W4220932718 creator A5031977714 @default.
• W4220932718 creator A5033935955 @default.
• W4220932718 creator A5036019538 @default.
• W4220932718 creator A5042854419 @default.
• W4220932718 creator A5056235620 @default.
• W4220932718 creator A5073926476 @default.
• W4220932718 creator A5082526059 @default.
• W4220932718 creator A5083858828 @default.
• W4220932718 date "2022-03-25" @default.
• W4220932718 modified "2023-10-09" @default.
• W4220932718 title "Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel" @default.
• W4220932718 cites W1979829306 @default.
• W4220932718 cites W1982589145 @default.
• W4220932718 cites W2040594411 @default.
• W4220932718 cites W2082708772 @default.
• W4220932718 cites W2092901728 @default.
• W4220932718 cites W2102636708 @default.
• W4220932718 cites W2103452148 @default.
• W4220932718 cites W2110818436 @default.
• W4220932718 cites W2119147717 @default.
• W4220932718 cites W2136060045 @default.
• W4220932718 cites W2169876627 @default.
• W4220932718 cites W2219506342 @default.
• W4220932718 cites W2509364267 @default.
• W4220932718 cites W2518731208 @default.
• W4220932718 cites W2598700764 @default.
• W4220932718 cites W2773804840 @default.
• W4220932718 cites W2895926103 @default.
• W4220932718 cites W2900391822 @default.
• W4220932718 cites W2903062212 @default.
• W4220932718 cites W2903225254 @default.
• W4220932718 cites W2911964244 @default.
• W4220932718 cites W2984531433 @default.
• W4220932718 cites W2987075075 @default.
• W4220932718 cites W3015500081 @default.
• W4220932718 cites W3034030759 @default.
• W4220932718 cites W3035443948 @default.
• W4220932718 cites W3082855561 @default.
• W4220932718 cites W3099478002 @default.
• W4220932718 cites W3166249517 @default.
• W4220932718 doi "https://doi.org/10.1186/s40164-022-00268-z" @default.
• W4220932718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35337365" @default.
• W4220932718 hasPublicationYear "2022" @default.
• W4220932718 type Work @default.
• W4220932718 citedByCount "9" @default.
• W4220932718 countsByYear W42209327182022 @default.
• W4220932718 countsByYear W42209327182023 @default.
• W4220932718 crossrefType "journal-article" @default.
• W4220932718 hasAuthorship W4220932718A5008075505 @default.
• W4220932718 hasAuthorship W4220932718A5016684714 @default.
• W4220932718 hasAuthorship W4220932718A5031977714 @default.
• W4220932718 hasAuthorship W4220932718A5033935955 @default.
• W4220932718 hasAuthorship W4220932718A5036019538 @default.
• W4220932718 hasAuthorship W4220932718A5042854419 @default.
• W4220932718 hasAuthorship W4220932718A5056235620 @default.
• W4220932718 hasAuthorship W4220932718A5073926476 @default.
• W4220932718 hasAuthorship W4220932718A5082526059 @default.
• W4220932718 hasAuthorship W4220932718A5083858828 @default.
• W4220932718 hasBestOaLocation W42209327181 @default.
• W4220932718 hasConcept C121608353 @default.
• W4220932718 hasConcept C126322002 @default.
• W4220932718 hasConcept C143998085 @default.
• W4220932718 hasConcept C156957248 @default.
• W4220932718 hasConcept C203014093 @default.
• W4220932718 hasConcept C207103383 @default.
• W4220932718 hasConcept C2777701055 @default.
• W4220932718 hasConcept C2780850621 @default.
• W4220932718 hasConcept C3875195 @default.
• W4220932718 hasConcept C44249647 @default.
• W4220932718 hasConcept C71924100 @default.
• W4220932718 hasConceptScore W4220932718C121608353 @default.
• W4220932718 hasConceptScore W4220932718C126322002 @default.
• W4220932718 hasConceptScore W4220932718C143998085 @default.
• W4220932718 hasConceptScore W4220932718C156957248 @default.
• W4220932718 hasConceptScore W4220932718C203014093 @default.
• W4220932718 hasConceptScore W4220932718C207103383 @default.
• W4220932718 hasConceptScore W4220932718C2777701055 @default.
• W4220932718 hasConceptScore W4220932718C2780850621 @default.
• W4220932718 hasConceptScore W4220932718C3875195 @default.
• W4220932718 hasConceptScore W4220932718C44249647 @default.
• W4220932718 hasConceptScore W4220932718C71924100 @default.
• W4220932718 hasIssue "1" @default.
• W4220932718 hasLocation W42209327181 @default.
• W4220932718 hasLocation W42209327182 @default.
• W4220932718 hasLocation W42209327183 @default.
• W4220932718 hasOpenAccess W4220932718 @default.
• W4220932718 hasPrimaryLocation W42209327181 @default.
• W4220932718 hasRelatedWork W2804529914 @default.
• W4220932718 hasRelatedWork W2916176185 @default.
• W4220932718 hasRelatedWork W2969241243 @default.
• W4220932718 hasRelatedWork W3017329712 @default.
• W4220932718 hasRelatedWork W3029666038 @default.
• W4220932718 hasRelatedWork W3038392370 @default.
• W4220932718 hasRelatedWork W3154231528 @default.
• W4220932718 hasRelatedWork W3162666314 @default.
• W4220932718 hasRelatedWork W4291298148 @default.

• next